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ABSTRACT 
Objective: The present study investigates the protective effects of crude extract from seeds of Entada phaseoloides and isolated compounds in 
enhancing cognition in Scopolamine induced learning and memory impairments in the radial arm maze model. 
Methods: Two doses (100 and 200 mg/kg) of the crude methanolic extract of Entada phaseoloides (MEEP) were evaluated for amnesic activity by 
Radial Arm Maze memory model. Scopolamine (0.4 mg/kg i. p.), an amnestic drug was used for impairing memory. Tacrine (3 mg/kg, i. p.) was used 
as the standard drug. Animals were sacrificed to evaluate biochemical parameters viz. lipid peroxidase (LPO), nitrite oxide (NO), reduced 
glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), cytokine levels by ELISA, Catecholamine levels by high performance liquid 
chromatography (HPLC), Caspase-3 activity by Fluorogenic assay, Gene (BDNF, TrkB, NF-κB p65, BAX) expression studies by Western Blotting and 
AChE, α7nAchR, Caspase-3, Nrf2 and HO-1 by Reverse Transcriptase Polymerase Chain Reaction. 
Results: Treatment with MEEP significantly decreases escape latency and reference memory error (RME). MEEP treatment reversed the 
Scopolamine-induced hyperactivation of Acetylcholinesterase activity and overexpression of proteins NF-κB p65 BAX and also Caspase-3 activity in 
the hippocampus of rats. The level of BDNF, TrkB and α7nAchR were significantly up-regulated and AChE, Caspase-3, Nrf2, HO-1 were down-
regulated in the MEEP treated rat. The extract increased the activity of SOD, GSH, Catalase, 5-HT, NE, Dopamine and decreased the levels of LPO and 
NO in rat hippocampus. Different active components of the seeds have been isolated. 
Conclusion: These results indicated that seeds of Entada phaseoloides might become a promising therapeutic agent for the treatment of cognitive 
dysfunction in addition to its already established medicinal properties. 
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Since long human progress is utilizing plant and plant-derived 
products as a source of medicine. As the plants possess powerful 
activity against several diseases, in the recent scientific 
developments, so many medicinal properties of such plants have 
been investigated throughout the world. It possesses another 
advantage like no side effects and economic plausibility [1]. In spite 
of rich biodiversity in India and the traditional knowledge available 
through Ayurveda, Unani and Homeopathy, the pharmacological 
misuse of these therapeutic plants has still been constrained. 
Though some of the plants have been extensively investigated, 
others await thorough investigation. Not only this, the scientific 
validation of the traditional value of the medicinal plants needs 
careful investigation [2].  
Alzheimer’s disease is one of most common neurodegenerative 
disorders and a major health issue in the aging population. 
Neurodegenerative disorders are clinically characterized by a 
progressive loss of cognitive abilities, which affects learning and 
memory dysfunction in daily activity. Learning is defined as the 
acquisition of information and skills, and subsequent retention of 
that information is called memory. Learning and memory are 
fundamental higher brain functions that allow the individual to 
adapt to the environment [3]. The major factor in Alzheimer's 
disease is due to the release of free radicals generated within the 
brain [4]. The pathogenesis of neurodegenerative disorders still 
remains uncertain. However, the deposition of neurofibrillary 
tangles and/or senile plaques, neuro-excitotoxicity and cholinergic 
dysfunction are known to be causative factors. The cholinergic 
system, including cholinergic neurons, neurotransmitters, and their 
specific receptors play a central role in the memory process 
(encoding, memory storage, and retrieval). As a neurotransmitter, 
acetylcholine obviously enhances long-term potentiation (LTP) in 
the basal forebrain and hippocampus. These cholinergic functions are 
mediated by neurotrophins such as brain-derived neurotrophic factor 
(BDNF) and nerve growth factor (NGF), which maintain neuronal 
plasticity and synaptogenesis. Acetyl cholinesterase inhibitors and the 
agents that modulate cholinergic dysfunction, such as donepezil, 
rivastigmine, galantamine, and tacrine, have been used to treat 
patients with amnesia-related disorders such as Alzheimer’s disease. 
However, these agents are not curatives, but are used to delay the 
progression of the disease and ameliorate the pathognomonic 
symptoms. Meanwhile, several study groups have recently analyzed 
the memory enhancing activities of herb derived natural product. 
Impairment of memory by anti-cholinergic actions of scopolamine 
(muscarinic receptor blocker) is a useful model for evaluating anti-
amnesic effects of drugs [5, 6]. Scopolamine causes oxidative stress 
in rats leading to cognitive impairment. We have selected this model 
as one of most suitable method to study dementia [7]. Although the 
fact, the free radicals increase oxidative stress in brain leading to 
memory impairment, but its exact mechanism is still not clear. 
Entada phaseoloides (Linn.) Merr. (Family: Fabaceae) is a well-
known medicinal plant distributed throughout the sub-Himalayan 
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tract (from Nepal eastwards ascending to 4,000 ft. in Sikkim, in 
Assam, Bihar and Orissa) and in the monsoon forest of Western and 
Eastern Ghats. It is also abundant in Andaman and Nicobar Islands. 
Almost all of the parts this plant is used in indigenous systems of 
medicine, the people in tropical and sub-tropical regions of countries 
made preparations for the treatment of a wide variety of illnesses, 
including hemorrhoids, stomachache, toothache, spasm, gastritis, 
and lymphadenitis [8]. A paste prepared from the seeds is applied 
locally for inflammatory glandular swellings. A glycoside of 
entagenic acid possesses anti-neoplastic activity [9]. Previous 
investigations on the chemical constituents of this plant have yielded 
saponins, flavonoids, and terpenoids [10-13]. Dawane et al. [14] 
studied the effect of two formulations of Entada phaseoloides seeds 
after topical application in ‘monoiodoacetate-induced osteoarthritis’ 
in rats, since arthritis is a very common clinical condition affecting 
both sexes and all ages.  
It is believed by the natives of Africa, that few species available there, 
have potent memory enhancing ability, which even enable them to 
communicate with their ancestors if taken at bedtime. However, there 
are no scientific evidences/reports of such claim or belief. As part of 
our continuing studies, efforts were directed towards identification of 
acetylcholinesterase (AChE) activity inhibitory constituents from this 
Indian medicinal plant. An initial screening was conducted using 
Morris Water Maze in mice (communicated). Methanolic extract of 
seeds of Entada phaseoloides showed promising activity against 
Scopolamine induced dementia in mice. Bioactivity-guided 
phytochemical analysis of methanolic extract led to the isolation and 
identification of four compounds (1-4). In this paper, we have 
presented AChE inhibitory activity of the crude extract along with 
isolation and structure elucidation of the isolated constituents.  
MATERIALS AND METHODS 
Drug and chemicals 
For this study, Scopolamine hydrobromide, Tacrine hydrochloride 
(9-Amino-1, 2, 3, 4-tetrahydro-acridine hydrochloride hydrate), 
Acetylthiocholine iodide, 5,5’-dithio-bis-nitrobenzoic acid (DTNB), 
Griess reagent, Dopamine hydrochloride, Serotonin hydrochloride 
and Tetramethylbenzidine (TMB) were obtained from Sigma-
Aldrich, USA. Enzyme-linked immunosorbent assay (ELISA) Kit was 
procured from RayBio®, USA, RIPA lysis buffer from Amresco, USA 
and Canada. All other chemicals and reagents used in the present 
work were of analytical grades. 
Animals studies 
Adult male Wistar rats (170–200 g) were procured from the 
Department of Pharmacology and Toxicology, College of Veterinary 
Science, Assam Agricultural University, Guwahati, Assam. They were 
housed in polypropylene cages, with clean bedding materials, safe 
drinking water, 12 h light-dark cycle, fed standard laboratory food 
and water was given ad libitum. All experiments were performed 
according to the current guidelines for the care of laboratory 
animals by IAEC (Approval No.770/ac/CPCSEA/FVSc, AAU/ 
IAEC/11-12/118); the effort was made to minimize the suffering of 
the experimental animals throughout the study. 
Plant collection and identification 
The dried seeds of Entada phaseoloides were collected from local 
market during the month of April-May, 2016 and identified by 
taxonomist Dr. Iswar Chandra Barua, Principal Scientist, Department 
of Agronomy, Assam Agricultural University, Jorhat, Assam and a 
voucher specimen was deposited and kept at the herbarium of the 
Department of Agronomy, Assam Agricultural University, Jorhat-
785013, Assam [AAU/EVM/NW-3]. 
Preparation of methanolic extract 
After removing the kernel from the seeds, they were shade dried, 
powdered mechanically, weighed and stored in airtight container. 
Then, 250 g of powdered material was soaked in 1000 ml methanol 
for 72 h in a beaker and mixture was stirred every 18 h using a 
sterile glass rod. Filtrate was obtained three times with the help of 
Whatman filter paper no.1 and the solvent was removed by a rotary 
evaporator (BUCHI, R-210, Labortechnik AG, Meierseggstrasse 
Switzerland) under reduced pressure leaving a dark brown residue 
(MEEP). It was stored in an airtight container at 4 °C until use. The 
recovery percentage with respect to dry powder was found to be 
26.52% w/w. 
Acute toxicity studies 
The acute toxicity studies of methanolic extract of Entada 
phaseoloides were performed according to the organization of 
economic corporation development (OECD) Guidelines No.423 by 
using albino mice of either sex (20-30g). The extracts were 
administered orally at 2000 mg/kg to a group of mice (n=3) and the 
percentage mortality, if any, was recorded. The animals were kept 
under observation for next 14 d for mortality or gross abnormality 
with the given doses. Based on the acute toxicity study, 100 and 200 
mg/kg oral dose were selected for the present study. 
Study design 
The experimental rats were divided into 5 groups (n=6 in each 
group).  
Group I: Normal control received only Saline,  
Group II: Negative control, received scopolamine 0.4 mg/kg, i.p.  
Group III: Standard control, received Tacrine 3 mg/kg, i.p. 
+scopolamine, 0.4 mg/kg i. p.  
Group IV: Methanolic extract of Entada phaseoloides 100 mg/kg, p.o. 
+scopolamine 0.4 mg/kg i. p.  
Group V: Methanolic extract of Entada phaseoloides 200 mg/kg p. 
o.+scopolamine 0.4 mg/kg i. p.  
Behavioural studies 
Radial arm maze 
For studying spatial working memory in rats, radial arm maze (RAM) 
experiment is carried out [15, 16]. The first entry into never-baited 
arms was scored as a reference memory error (RME). The behavioural 
recording was done by Any Maze apparatus (Stoelting and Co., USA). 
Biochemical estimation 
Biochemical tests were done 24 h after the last behavioral test. The 
total protein was estimated by the method of Bradford et al. [17]. 
Assessment of oxidative stress and antioxidant status 
The pro-oxidant markers i.e. lipid peroxidation (LPO) [18] and nitric 
oxide (NO) [19], antioxidant proteins i.e. reduced glutathione (GSH) 
[20], superoxide dismutase (SOD) [21], catalase (CAT) [22] were 
measured spectrophotometrically (MultiscanGo, Thermo Fisher) as 
per standard protocol. 
Estimation of β-Amyloid 1-42 
The level of β-amyloid1-42 in the brain tissue was done by sandwich 
ELISA using rat β amyloid1-42 (Bioassay Technology laboratory, 
Shanghai, China) kit. 
Estimation of inflammatory cytokines 
The levels of inflammatory cytokines (IL-1β and TNF-α) in the brain 
tissue were estimated using commercially available cytokine ELISA 
kits (Ray Biotech, USA) according to the manufacturer’s instructions. 
Estimation of norepinephrine (NE), dopamine (DA) and 
serotonin (5-HT) 
NE, DA, and 5-HT concentrations were simultaneously estimated in 
the hippocampus with slight modification [23] using high-
performance liquid chromatography with an electrochemical 
detector (UHPLC, Thermo Scientific Dionex Ultimate 3000, USA and 
Coulochem III electrochemical detector, Acclaim® 120 C18 Column 
4.6x250 mm 5 μm). 
Estimation of Caspase-3 using a fluorogenic substrate 
Caspase3 activity was measured using specific substrate Ac-DEVD-
AMC (Sigma) in Fluoroskan Ascent (Thermo Scientific).  
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SDS-PAGE and Immunoblot analysis  
The expression of the TrkB, BDNF, NF-κB p65 and BAX proteins in the 
hippocampus was analyzed by Western Blotting using a Hoefer Midi 
Gel apparatus (Harvard Apparatus, Holliston, MA). Approximately, 30 
mg tissue of the hippocampus was homogenized in 5 ml of chilled lysis 
buffer (RIPA Buffer, Amresco, USA) and centrifuged (23,000 × g) for 20 
min at 4 °C. The protein concentration of the supernatants was 
quantified by Bradford reagent (Himedia) with Bovine serum albumin 
(BSA) as the standard. Samples with 50µg of total protein were mixed 
with an equal volume of 2X Laemmli buffer, boiled for 5 min at 95 °C 
cooled, loaded and separated in 10% polyacrylamide gels containing 
sodium dodecyl sulfate (SDS). The separated proteins were 
transferred to PVDF membranes for immunoblot analysis. After 
blocking with 3% Bovine serum albumin in 1X TBST for 1 h at room 
temperature, the membranes were incubated overnight at 4 °C with 
primary antibodies (β-Actin, TrkB, BDNF, NF-κB p65 and BAX) at a 
dilution of 1:500; Santa Cruz Biotechnology, Santa Cruz, CA. On the 
following day, they were washed with 1X TBST and incubated with 
respective secondary antibodies conjugated to Horseradish 
peroxidase (HRP) (Santa Cruz Biotechnology, Inc) for 1 h at a dilution 
of 1:5000. The bands were visualized using TMB Blotting solution 
available commercially. The band intensities were quantified using 
Image J software (NIH, Bethesda, MD, USA). 
Reverse transcriptase PCR (RT-PCR) 
AChE, α7nAchR, Caspase-3, Nrf2 and HO-1 mRNA expressions were 
studied in the hippocampus tissue of rat brain by reverse 
transcriptase polymerase chain reaction. RNA was isolated from the 
hippocampus using TRIzol (Ambion). The concentration and purity 
of RNA were determined spectrophotometrically using micro drop 
plate. Approximately 1 µg of total RNA was reverse transcribed 
using RevertAid First Strand cDNA synthesis kit (Thermo Scientific). 
The resultant cDNA was amplified separately with specific primer 
for AChE, α7nAchR, Caspase-3, Nrf2, HO-1, and Gapdh using 
DreamTaq Green PCR Master mix (2X) (Thermo Scientific). The 
Polymerase Chain reaction mixture was amplified in a Thermal 
cycler consisting of 5 µl of 2X PCR master mix, 0.5 µl of forward and 
reverse primer (10pmol/µl), 1 µl of template and nuclease-free 
water to a total volume of 10 µl. The primers used for amplification 
are shown in table 1. All PCR samples were denatured at 95 °C for 3 
min before cycling and were extended for 10 min at 72 °C after 
cycling. The PCR assay using primers was performed for 35 cycles at 
95 °C for 30 s, annealing temperature varies for different primers for 
45 s (table 1) and 72 °C for 45 s. The PCR products were detected by 
electrophoresis on a 2% agarose gel containing ethidium bromide 
and the densities of each band were analyzed by an image analyzer 
(Image J). 
 
Table 1: Sequence of the primers used in RT-PCR analysis 
Gene Primer sequence (Forward and reverse) Product size (base pair) Annealing temp ( °C) 
AChE Forward 5′-GATCCCTCGCTGAACTACACC-3' 331 60 °C 
 Reverse5′-GGTTCTTCCAGTGCACCATGTAGGAG-3'   
Nrf2 Forward 5′-GAGACGGCCATGACTGAT-3′ 196 58 °C 
 Reverse 5′-GTGAGGGGATCGATGAGTAA-3′   
HO-1 Forward 5′-AAGAGGCTAAGACCGCCTTC-3′ 262 60 °C 
 Reverse 5′-GCATAAATTCCCACTGCCAC-3′   
GAPDH Forward 5′-AGGTTGTCTCCTGTGACTTC-3′ 130 58 °C 
 Reverse 5′-CTGTTGCTGTAGCCATATTC-3′   
Caspase-3 Forward 5′-AATTCAAGGGACGGGTCATG-3′ 105 60 °C 
 Reverse 5′-GCTTGTGCGCGTACAGTTTC-3′   
α7nAchR Forward 5′-GAGTCTGCAGGCAGCAAGAATAC-3′ 510 60 °C 
  Reverse 5′-GTGGAACATGTCTGAGTACCCCG-3′     
 
Statistical analysis 
Results are expressed as mean±SEM. Statistical analysis was 
performed by one-way analysis of variance (ANOVA) followed by 
post hoc Tukey’s multiple range tests, using Graph Pad Prism 
software version 5.0 (San Diego, CA, USA). Results were considered 
statistically significant when p<0.05. 
RESULTS 
Chemistry 
The fractionation and purification led to the isolation of 4 
compounds in the crude methanolic extract from the seeds of Entada 
phaseoloides. The structures of isolates were established using IR, 
MS, 1D and 2D NMR spectroscopic techniques. After comparing their 
spectral data with those reported in the literature [24], they were 
identified as known compounds (fig. 1) and confirmed as Oleic acid 
(1), Entadamide A (2), Entadamide A-beta-D-glucopyranoside (3) 
and 1-O-protocatechuoyl-β-D-glucose (4). (fig. 1) 
Isolation of compounds from Entada phaseoloides 
The methanolic extract (10g) was subjected to column 
chromatography (silica gel, 100-200 mesh, eluting with hexane/ 
EtOAc mixture of increasing polarity) to give 40 column fractions. 
Column fractions were analyzed by TLC (silica gel 60 F254, hexane: 
EtOAc, 60:40), and fractions with similar TLC patterns were 
combined to give five major fractions (F1, F2, F3, F4, F5). Fractions F4 
was subjected to repeated column chromatography eluting with 
EtoAc: hexane (19:81) to yield compound 1. Fraction F3 was 
subjected to column chromatography(CC) on silica gel (100-200 
mesh) using a hexane-EtOAc (10:0-6:4) to yield subfractions B1 and 
Compound 2. Subfraction B1 was then purified by preparative TLC 
with CHCl3: MeOH (90:10) to get compound 3. Repeated purification 
of fraction F4 on silica gel (230-400 mesh) using CHCl3: MeOH 
(yu90:10) followed by Preparative HPLC, yielded compound 4. 
Spectral data for isolates 
Oleic acid (1): Light yellow oil, 1H-NMR (500 MHz, CDCl3) δ: 5.35 
(2H, m), 2.33(4H, m), 2.01 (4H, m), 1.64 (4H, m),1.37-1.22(H, m), 
0.88 (3H, t, J = 7.1 and 6.2 Hz). 13C NMR (CDCl3, 75 MHz) δ: 180.55, 
129.93, 129.63, 34.11, 31.91, 29.76, 29.66, 29.60, 29.53, 29.37, 29.32, 
29.14, 29.05, 27.20, 27.13, 24.64, 22.67, 14.05. HR-ESI-MS m/z: 
305.2456 (Calcd for C18H24O2Na: 305.2451). 
Entadamide A (2): White amorphous powder, 1H-NMR (500 MHz, 
CDCl3) δ: 7.62 (1H, d, J = 14.5Hz), 6.44(1H, br s), 5.69(1H, d, J = 14.6 
Hz), 3.71(2H,m), 3.46 (2H, m), 2.32 (3H,s). 13C NMR (CDCl3, 75MHz) 
δ: 165.80, 143.67, 115.31, 62.46,42.49, 14.60. HR-ESI-MS m/z: 
162.0589 (Calcd for C6H12NO2S: 162.0583). 
Entadamide A-beta-D-glucopyranoside (3): White amorphous 
powder, 1H-NMR (500 MHz, CD3OD) δ: 2.33 (3H, s), 3.27 (1H, m), 
3.29 (1H, m,), 3.35 (1H, m), 3.37 (1H, m), 3.46 (1H, m), 3.72 (2H, m), 
3.90(1H, m), 3.96 (1H, m), 3.99 (1H, m,), 4.29 (1H, d, J = 7.9 Hz), 5.85 
(1H, d, J = 14.58Hz), 7.59 (1H, d, J = 14.58 Hz). 13C NMR (75 MHz, 
CD3OD): δ 165.58, 142.31, 114.83, 102.39, 75.8, 75.67, 72.97, 69.36, 
68.23, 60.74, 38.92, 13.4. HR-ESI-MS m/z: 346.0946 (Calcd for 
C12H21NO7S: 346.0931). 
1-O-protocatechuoyl-β-D-glucose (4): Color less gummy, 1H-NMR 
(500 MHz, DMSO-d6) δ: 6.91(1H, d, J = 8.68Hz), 6.59(1H, brs), 6.48 
(1H, dd, J = 8.6 and 2.5), 4.47(1H, d, J = 6.8), 3.69(1H, m), 3.47(1H, 
m), 3.37(1H, m), 3.18(3H, m). 13C NMR (75 MHz, CD3OD) δ: 174.56, 
152.15, 148.65, 129.14, 117.64, 117.12, 112.84, 103.74, 76.96, 76.45, 
73.43, 69.74, 60.88. 
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Fig. 1: The structures of the isolates: oleic acid (1), Entadamide A (2), Entadamide A-beta-D-glucopyranoside (3), 1-O-protocatechuoyl-β-
D-glucose (4) 
 
Radial arm maze study 
Effect of MEEP on escape latency and reference memory errors 
in rat 
Escape latency (Sec) 
In Radial Arm Maze, a significant decline in the escape latency 
(36.03±2.4 s) could be observed (p<0.001) in MEEP (200 mg/kg), 
followed by Tacrine and MEEP (100 mg/kg) treatment, when 
compared to Scopolamine treated group (143.0±6.7 s) (table 2). 
Reference memory error 
Numbers of error committed showed a decreasing trend (p<0.001) 
in MEEP (200 mg/kg), i.e., 0.28±0.030 s, followed by Tacrine and 
MEEP (100 mg/kg) when compared to Scopolamine treated 
(2.187±0.199 s) group (table 2). The Scopolamine treated group 
significantly increased (p<0.001) reference memory error 
compared to the control group. Reference Memory Error was 
ameliorated by the treatment of MEEP showing its anti-amnesic 
activity. 
 
Table 2: Effect of MEEP on escape latency and reference memory error in rat hippocampus with scopolamine-induced memory 
impairment in radial arm maze, values are expressed as mean±SEM (n=6). Statistical significance was determined by one-way ANOVA 
followed by Tukey’s post hoc test; p<***, p<### when compared to control and Scopolamine treated group respectively 
Groups Escape latency (s) Reference memory error 
Vehicle Control 53.92±1.20 0.08±0.01 
Scopolamine treated (0.4 mg/kg i. p.) 143.0±6.71 2.19±0.19 
Tacrine (3 mg/kg i. p.)+Scop. 60.28±0.22 0.65±0.08 
MEEP (100 mg/kg p. o.)+Scop. 66.31±0.60 1.32±0.03 
MEEP (200 mg/kg p. o.)+Scop. 36.03±2.41###  0.28±0.03### 
 
Effect of MEEP on brain Acetylcholinesterase (AChE) activity in 
rat 
The AChE levels in the hippocampus of scopolamine treated rats 
elevated significantly (p<0.001), when compared to the control 
group. Whereas, MEEP treatment remarkably decreased the level of 
AChE activity compared with Scopolamine induced group (p<0.001 
at 100 and 200 mg/kg oral doses) (155.3±2.02 nM/min/mg, 
146.7±1.45 nM/min/mg) (fig. 2).  
The standard drug, Tacrine also significantly reduced (p<0.001) the 
AChE activity in the hippocampus. 
Effect of MEEP on antioxidants in rat 
Antioxidants enzymes, GSH, SOD and Catalase, showed a significant 
decline (p<0.001) in Scopolamine treated group when compared to 
control. Whereas, the levels were found to elevate significantly 
(44.00±0.57 µg/mg, 2.77±0.01 U/mg, 32.06±0.67 nMol/min/mg) 
(p<0.001) in MEEP 200 mg/kg, p. o. dose respectively (fig. 3C, 3D, 
3E) treated group when compared to Scopolamine treated group. A 
complete reversal in LPO and NO levels could be observed in 
Tacrine, MEEP (100 and 200 mg/kg) treated groups at significantly 
decreasing (37.00±1.73 nMol/g, 35.33±0.88 µg/mg) (p<0.001) (fig. 
3A, 3B) levels respectively, when compared to scopolamine treated 
group. These levels thus ascertained the antioxidant property of our 
plant. 
 
Fig. 2: Effect of MEEP on acetylcholinesterase level in rat 
hippocampus with scopolamine-induced memory impairment 
in Radial arm maze. Values are expressed as mean±SEM (n=6). 
Statistical significance was determined by one-way ANOVA 
followed by tukey’s post hoc test; p<***, p<### when 
compared to control and Scopolamine treated group 
respectively 
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Fig. 3: Effect of MEEP in rat hippocampus with scopolamine-induced impaired memory in radial arm maze model on the levels of A) LPO 
B) NO C) GSH D) SOD and E) catalase, values are expressed as mean±SEM (n=6), statistical significance was determined by one-way 
ANOVA followed by Tukey’s post hoc test; ***p<0.001, ###p<0.001, when compared to control and scopolamine, treated group respectively 
 
Effect of MEEP on pro-inflammatory cytokines (IL-1β and TNF-
α) and β-amyloid in rat 
Immunological assay by ELISA in the hippocampus of Scopolamine 
treated animals, revealed a significant (p<0.001) elevation in the 
levels of pro-inflammatory cytokines viz. IL-1β (3018±89.63 pg/ml) 
and TNF-α (5764±21.50 pg/ml) in Scopolamine treated group, when 
compared to control, while a significant (p<0.001) decline in the 
cytokine levels could be observed MEEP 200 mg/kg treated animals 
(1361±33.01 pg/ml, 2439±29.41 pg/ml) when compared to 
Scopolamine treated group (fig. 4A, 4B). 
  
 
Fig. 4: Levels of pro-inflammatory cytokines A) IL-1β, B) TNF-α, C) β-amyloid in the rat hippocampus by ELISA in radial arm maze model. 
Values are expressed as mean±SEM (n=6). Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test; 
***p<0.001, ###p<0.001, when compared to control and Scopolamine, treated group respectively 
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Effects of MEEP on NE, DA and 5-HT levels in the hippocampus 
in Scopolamine induced rat. 
Scopolamine significantly reduced NE (96.96±6.2 ng/gm), DA 
(49.78±3.77 ng/gm), and 5-HT (67.16±3.35 ng/gm) concentrations 
in the hippocampus compared to control animals. Administration of 
MEEP 100 mg/kg p. o. (fig. 5) was able to reverse the effects of 
scopolamine on reduced NE (162.8±12.49 ng/gm), DA (310±14.16 
ng/gm) and 5-HT (90±5.62 ng/gm) concentrations. Likewise, the 
standard drug Tacrine reversed the effects of scopolamine on NE, DA 
and 5-HT (fig. 5) 
 
 
Fig.5: Effects of MEEP on NE, DA and 5-HT levels in rat 
hippocampus with Scopolamine induced memory loss. All values 
are mean±SEM. #p<0.05 and ##p<0.01 versus control group and 
*p<0.05 and **p<0.01 versus Scopolamine induced group 
 
Effect of MEEP on caspase-3 using a fluorogenic substrate 
Fluorogenic assay of Caspase-3 revealed a significant decline in the 
levels in Tacrine (p<0.001) and MEEP (200 mg/kg) (0.0035±0.00 
nMol/ml/min) (p<0.05) (fig. 6), when compared to the scopolamine 
0.0038±0.00 nMol/ml/min) treated group. Thus, confirming the 
anti-apoptotic activity similar to that of the standard drug (fig. 6) 
 
Fig. 6: Fluorescence-based caspase-3 activity assay showing its 
expression levels in rat hippocampus with scopolamine-
induced impaired memory. Values are expressed as nMol of 
AMC/ml/min represented as mean±SEM (n=6). Statistical 
significance was determined by one-way ANOVA followed by 
Tukey’s post hoc test; ***p<0.001 when compared to control and 
###p<0.001 when compared to Scopolamine group 
 
Immunoblotting analysis of NF-κB p65, BAX, BDNF and TrkB 
The Immunoblotting assay of NF-κB p65, BAX, BDNF and TrkB 
showed significant down-regulation of BDNF (p<0.01) and TrkB 
(p<0.001) protein in the hippocampal tissue of scopolamine-induced 
rats compared to control group. However, pre-treatment with MEEP 
significantly up-regulated BDNF (100 and 200 mg/kg; p<0.05, 
p<0.01) and TrkB (100 and 200 mg/kg; p<0.01, p<0.001) protein 
expression in the hippocampal tissues of rat similar to Tacrine 
(p<0.01, p<0.001 in BDNF and TrkB), as compared to scopolamine 
treated rats. On the other hand, significant (p<0.001) up-regulation 
in the expression of BAX and NF-κB p65 in the hippocampal tissue of 
scopolamine-induced rats compared to the control group were 
observed. Pre-treatment with MEEP significantly downregulated 
BAX (100 and 200 mg/kg; p<0.001, p<0.01) and NF-κB p65 (100 and 
200 mg/kg; p<0.05, p<0.001) protein in the hippocampal tissues of 
rat similar to that of standard drug Tacrine (p<0.01, p<0.001), when 




Fig. 7: Quantitative expression of NF-κB p65, BAX, BDNF and TrkB genes by western blotting in different treatment groups viz. Control, 
Scopolamine, Tacrine, MEEP (100 mg/kg), MEEP (200 mg/kg) in rat hippocampus with Scopolamine induced memory loss. Values are 
expressed as percent fold change represented as mean±SEM (n=6). Statistical significance was determined by one-way ANOVA followed 
by Tukey post hoc test; ***p<0.001 when compared to control, ### p<0.001 when compared to Scopolamine group 
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RT-PCR analysis of AChE, α7nAChR, Caspase-3, Nrf2 and HO-1 genes 
The RT-PCR analysis of AChE, α7nAChR, Caspase-3, Nrf2 and HO-1 
gene expression are presented (fig. 8), the mRNA expression levels 
of AChE, α 7nAChR, Caspase-3, Nrf2 and HO-1 were significantly 
(p<0.001, p<0.001, p<0.001, p<0.001 and p<0.05) up-regulated in 
the hippocampal tissues of scopolamine-induced rats, respectively, 
compared to the control group. However, pre-treatment with MEEP 
significantly down-regulated the mRNA expression of AChE (MEEP 
200 mg/kg; p<0.001), Nrf2 (MEEP 100 and 200 mg/kg; p<0.001), 
Caspase-3 (MEEP 100 and 200 mg/kg; p<0.001) and HO-1 (MEEP 
100 and 200 mg/kg; p<0.001) genes’ expression in the hippocampal 
tissues of rat, similar to that of standard drug, Tacrine as compared 
to the scopolamine treated rats. On the other hand, mRNA 
expression levels of α7nAChR were significantly (p<0.01) down-
regulated in the hippocampal tissues of scopolamine treated rats 
compared to the control group. Pre-treatment with MEEP (100 and 
200 mg/kg) significantly upregulated the mRNA expression of α7nAChR 
(p<0.001, p<0.001) gene in the hippocampal tissues of rat similar to 
Tacrine, when compared with scopolamine treated group (fig. 8). 
 
 
Fig. 8: Quantitative expression of Alpha-7-nAChR, AChE, Caspase-3, Nrf2 and HO-1 gene by Reverse Transcriptase PCR in different 
treatment groups viz. Control, Scopolamine, Tacrine, MEEP (100 mg/kg), MEEP (200 mg/kg) in rat hippocampus with Scopolamine 
induced memory loss. Values are expressed as percent fold change, represented as mean±SEM (n=6). Statistical significance was 
determined by one-way ANOVA followed by Tukey post hoc test; ***p<0.001 when compared to control, ###p<0.001, when compared to 
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Among the neurodegenerative disorders, memory impairment is the 
most typical feature, which results from neuronal dysfunction and 
neuronal loss in the brain tissues, particularly the hippocampal 
region [25]. There is no effective way to cure the disorder or stop the 
neurodegenerative processes. Thus, research has been focused on 
discovering how to intercede neuro-degeneration of Alzheimer 
disease. Currently, ethnobotanical and traditional uses of natural 
compounds, especially of plant origin received much attention, as 
they are well tested for their efficacy which is believed to be safe. 
They clearly merit examination on present-day logical lines, for 
example, phytochemical examination, organic assessment on 
exploratory creature models, examination of the sub-atomic system 
of activities of detached phyto-standards and their clinical 
preliminaries. It is the best traditional approach looking for new lead 
atoms for the administration of different illnesses [26]. In our study, 
we examined the effects of Entada phaseoloides to alleviate memory 
deficits in radial arm maze model in rats. Pre-treatment with MEEP 
(200 mg/kg, p. o.) demonstrated a significant reduction of escape 
latency and a significant elevation of reference memory error in 
Radial Arm maze. The results showed that MEEP (200 mg/kg) 
improved the cognitive performance in scopolamine-induced 
cognitive impairment in rats. 
The boost in cholinergic activity and inhibition of AChE enzyme is a 
promising therapy to treat a cognitive defect in Alzheimer's disease 
[27]. Administration of MEEP at 200 mg/kg oral dose significantly 
reversed the elevated AChE level. Thus, the results suggest that 
cognition enhancing the property of MEEP could be due to inhibition 
of AChE enzyme. 
Free radicals are compound or substances that can exist 
independently with at least one unpaired electron. The proliferation 
of free radicals can achieve a large number of responses and 
subsequently may cause extensive tissue injury. Antioxidants may 
offer resistance against oxidative stress by scavenging the free 
radicals, inhibiting lipid peroxidation etc. [28]. The scopolamine 
induced memory deficit model exhibits prominent oxidative stress 
and memory deficits, although the mechanism remains unclear [29, 
30]. The hippocampus plays a crucial role in short and long-term 
memory and highly susceptible to oxidative stress [31]. Our results 
show that scopolamine induction increased the levels of LPO and 
NO, following administration of MEEP or Tacine, significant 
attenuation of their levels was visible. 
To protect tissues against oxidative damage, cellular organisms 
maintain an antioxidant system containing enzymatic and non-
enzymatic components. SOD and catalase play an important role in 
the detoxification of superoxide anion and hydrogen peroxide 
respectively and protect the cells against oxidative damage induced 
by free radicals [32]. Our study shows that scopolamine significantly 
decreased the antioxidant capacity of SOD, Catalase and GSH in the 
hippocampus of rat brain, whereas pretreatment with MEEP 
significantly ameliorated these level to restore neuronal plasticity 
and memory function.  
Cognitive dysfunction is generally accompanied by elevated pro-
inflammatory cytokines and inflammation mainly in the hippocampal 
region. ROS under oxidative stress may initiate and exaggerate the 
inflammatory response due to their capability to stimulate and 
regulate the inflammatory-signaling cascades genes like NF-κB p65 
and pro-inflammatory cytokines [33]. Scopolamine-induced rats also 
showed increased NF-κB p65 activity, pro-inflammatory cytokines 
(TNFα, IL-1β), and due to increased oxidative stress. MEEP treatment 
led to a significant decrease in the NF-κB p65 activity and its 
downstream pro-inflammatory cytokines (TNFα, IL-1β).  
Aggregation of β amyloid protein in the brain tissue lead to cognition 
impairment which is characterized by plaque deposition in 
extracellular spaces, and β amyloid 1-42 is predominant in the brain. 
Pre-treatment with MEEP at the given dose resulted in a significant 
decrease in the amount of β amyloid 1-42 in the rat brain.  
In stressful conditions, change in dopamine level is associated with a 
transient change in behavioral aberrations, memory, learning 
disorders [34]. Administration of MEEP increased dopamine 
concentration in the scopolamine-induced amnesic model in the 
hippocampus, following 14 d of pre-treatment, revealed in HPLC 
analysis. The extract might show cognition enhancement by 
increasing dopamine level, which is more prominent than other 
catecholamines, namely, NE or 5HT observed in our experiment. 
In our phytochemical study, 4 compounds have been isolated and 
identified in the active compound. Oleic acid isolated from the seeds 
of Entada phaseoloides has many positive effects on health. Few 
reported its usefulness for proper brain function [35, 36]. 
Consumption of oleic acid replaces other omega fatty acids in cell 
membrane as it is less susceptible to oxidation damage. Oleic acid 
protects the cell membrane from free radical and other oxidative 
stressors [37]. E. phaseoloides could exert its effect due to its oleic 
acid component. Ikegami et al., 1989, reported that Entadamide A, 
has inhibitory activity on 5-Lipoxygenase pathway. Hence it might 
exert an anti-inflammatory effect. 
In our study, scopolamine induced apoptotic neuronal cell death by 
decreasing anti-apoptotic signalling (Bcl-2) and increasing apoptotic 
signalling (BAX and Caspase-3 activity). Suuronen et al. [38] showed 
that Scopolamine-induced apoptosis in cultured neuronal cells might 
be due to an increase in oxidative stress. Preventive treatment with 
MEEP led to decreased oxidative stress resulting in an improvement 
in anti-apoptotic (Bcl2) expression and decreased pro-apoptotic 
(BAX and Caspase-3 activity) genes indicating neuro-protection. 
BDNF could be a diagnostic biomarker in patients with early 
Alzheimer’s disease and mild cognitive impairment [39]. In the 
present study, the MEEP treatment almost restored the levels of the 
BDNF proteins, and its receptor, TrkB in the hippocampus, 
considerably downregulated by scopolamine. We observed that 
hippocampal BDNF level was significantly suppressed in the 
scopolamine-treated animal as compared to normal control group. 
Our study showed an up-regulation in hippocampal BDNF 
expression in the groups treated with MEEP like Tacrine. 
We examined the effects of MEEP on key modulators of the 
cholinergic system in the hippocampus. Hippocampal cholinergic 
dysfunction has been observed in neurodegenerative disorders with 
memory impairment, including Alzheimer’s disease, in both clinical 
studies [40] and animal experiments [41 and 42]. The scopolamine 
injection interrupts the transmission of acetylcholine into the post-
synaptic membrane, which sequentially enhances AChE activity to 
catalyse the hydrolysis of acetylcholine [43]. MEEP treatment 
attenuated the AChE activity and down-regulated the expression of 
the AChE, α7nAChR, Caspase-3, Nrf2, HO-1 mRNA. The inhibition of 
AChE activity enhances basal dendritic long-term potentiation (LTP) 
in the hippocampal CA1 (first region of the hippocampal circuit) 
area, and it is mediated by muscarinic M1 receptors [44]. To date, 
reversible cholinesterase inhibitors have been considered a 
promising strategy for the pharmacotherapy of mild to moderated 
Alzheimer’s disease [45]. It could be possible that MEEP possesses 
cholinergic property, which we could see in isolated rat ileum 
(unpublished report). 
Adult hippocampal neurogenesis plays an important role in memory 
formation. Therefore, impaired neurogenesis and neuronal 
integration are regarded as pathological features of 
neurodegenerative disorders [46]. As expected, the MEEP treatment 
notably reversed the scopolamine-induced inhibition of 
neurogenesis in the hippocampal region. This neurogenesis is 
known to depend on the activities of both neurotrophins and their 
receptors [47]. 
Taken together, this study for the first time showed that MEEP 
exerted anti-amnesic actions in scopolamine-induced amnesia. We 
have also investigated its effect on various models like Morris water 
maze, Barnes maze etc. in addition to in radial arm maze presented 
in this study. Its active compounds were also isolated by structural 
analysis; hence further study with the active compound may yield a 
new chemical entity. 
In summary, the present investigation sheds light on the potent 
neuroprotective potential of Entada phaseoloides seeds in 
Barua et al. 
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scopolamine-induced neurotoxicity. The effect is likely to result from 
the inhibition of Acetylcholinesterase enzyme activity, suppressing 
β-amyloid plaque formation, inhibition of oxido-nitrosative stress 
and pro-inflammatory cytokines elevation in the hippocampus. It 
also significantly ameliorated the cognitive dysfunction in 
scopolamine-treated animal’s up-regulating the expression of BDNF 
gene in the hippocampus, which is the hallmark for depression and 
memory-related disorders. 
CONCLUSION 
It is presumed from the present study that MEEP may be used as a 
therapeutic agent in the treatment of cognitive dysfunction-
associated disorders such as Alzheimer’s disease or any other 
neurodegenerative disorders. It will be interesting to study this 
plant to this direction for scientific validation. Hence, future research 
may be directed towards the use of pure/semi-pure compound 
isolated from the extract in clinical trials to evaluate its 
neuroprotective effect on human. 
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